Consolidated Revenue
$
$24.8B
▲ 12.4% vs Q3 '24
EBITDA Margin
%
28.6%
▲ 1.8pp expansion
Active Projects
1,842
● On Track
Carbon Offset
🌿
4.2Mt
▲ 18.3% vs target
Global Headcount
👥
348,200
▲ 2.1% net growth
Divisional Revenue Performance
Q3 2025
YTD
FY 2025
Energy
Tech
Aerospace
Healthcare
Finance
Real Estate
Logistics
Media
Revenue Target
Exceeded Target
Below Target
Regional Operations
Region Status Budget Util. Projects
North America Optimal 92.4% 412
Europe & UK Optimal 88.7% 385
Asia Pacific Review 95.1% 528
Middle East & Africa Optimal 84.2% 294
Latin America On Hold 62.8% 118
ESG & Sustainability Tracker
Compliant
Carbon Reduction 78%
Target: 100% by 2030. Q3: -4.2Mt CO2e
Supply Chain Ethics 94%
Audits completed: 1,240/1,320 tier-1 vendors
Workplace Diversity 68%
Leadership representation target: 75% by 2026
Recent Compliance & Audit Activity
  • Zenth Health Sciences passed FDA Phase III regulatory review for AZX-402 gene therapy.
    2 hours ago
  • Aevum Energy submitted revised environmental impact assessment for Neo-Genova offshore wind farm.
    1 day ago
  • Corporate Finance finalized $2.4B green bond issuance for cross-divisional decarbonization projects.
    3 days ago
  • Internal Audit completed Q3 cybersecurity penetration testing across APAC cloud infrastructure.
    5 days ago
Cross-Divisional Capital Allocation & ROI Forecast
Division Q3 Capital Deployed Forecasted ROI (12mo) Risk Rating Strategic Alignment Audit Status
Aevum Energy & Power $1.8B 14.2% Low
Cleared
Zenth Digital Systems $3.2B 22.8% Medium
Cleared
Aevum Aerospace & Defense $2.1B 18.5% Low
Pending
Zenth Health Sciences $1.4B 31.2% High
Cleared
Aevum Capital Group $4.5B 9.8% Low
Cleared